{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:59:14Z","timestamp":1793746754446,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47309-9","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:37:48Z","timestamp":1776094668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of microencapsulated sodium butyrate on abdominal symptoms and carbohydrate metabolism in patients with type 2 diabetes: a randomized placebo-controlled trial"],"prefix":"10.1038","volume":"16","author":[{"given":"Paulina","family":"Panufnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Wi\u0119cek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Szwarc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Szydlarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kadaj-Lipka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Franek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Rydzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"8","key":"47309_CR1","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1093\/jn\/132.8.2229","volume":"132","author":"T Tsukahara","year":"2002","unstructured":"Tsukahara, T., Koyama, H., Okada, M. & Ushida, K. Stimulation of butyrate production by gluconic acid in batch culture of pig cecal digesta and identification of butyrate-producing bacteria. J. Nutr. 132(8), 2229\u201334. https:\/\/doi.org\/10.1093\/jn\/132.8.2229 (2002).","journal-title":"J. Nutr."},{"issue":"2 Suppl 3","key":"47309_CR2","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.15167\/2421-4248\/jpmh2022.63.2S3.2745","volume":"63","author":"AK Kiani","year":"2022","unstructured":"Kiani, A. K. et al. Modern vision of the Mediterranean diet. J. Prev. Med. Hyg. 63(2 Suppl 3), E36\u2013E43. https:\/\/doi.org\/10.15167\/2421-4248\/jpmh2022.63.2S3.2745 (2022).","journal-title":"J. Prev. Med. Hyg."},{"key":"47309_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101756","volume":"67","author":"R Newsome","year":"2023","unstructured":"Newsome, R., Yang, Y. & Jobin, C. Western diet influences on microbiome and carcinogenesis. Semin. Immunol. 67, 101756. https:\/\/doi.org\/10.1016\/j.smim.2023.101756 (2023).","journal-title":"Semin. Immunol."},{"issue":"2","key":"47309_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020699","volume":"13","author":"C Garc\u00eda-Montero","year":"2021","unstructured":"Garc\u00eda-Montero, C. et al. Nutritional components in Western diet versus Mediterranean diet at the gut microbiota-immune system interplay: Implications for health and disease. Nutrients 13(2), 699. https:\/\/doi.org\/10.3390\/nu13020699 (2021).","journal-title":"Nutrients"},{"issue":"1","key":"47309_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5114\/pg.2021.112681","volume":"17","author":"K Lewandowski","year":"2022","unstructured":"Lewandowski, K., Kaniewska, M., Kar\u0142owicz, K., Roso\u0142owski, M. & Rydzewska, G. The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome. Gastroenterol. Rev. 17(1), 28\u201334. https:\/\/doi.org\/10.5114\/pg.2021.112681 (2022).","journal-title":"Gastroenterol. Rev."},{"key":"47309_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1099018","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson\u2019s disease by regulating gut microbiota. Front. Aging Neurosci. 15, 1099018. https:\/\/doi.org\/10.3389\/fnagi.2023.1099018 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"47309_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105314","volume":"164","author":"T Doifode","year":"2021","unstructured":"Doifode, T. et al. The impact of the microbiota-gut-brain axis on Alzheimer\u2019s disease pathophysiology. Pharmacol. Res. 164, 105314. https:\/\/doi.org\/10.1016\/j.phrs.2020.105314 (2021).","journal-title":"Pharmacol. Res."},{"key":"47309_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.785833","volume":"11","author":"K Schlatterer","year":"2021","unstructured":"Schlatterer, K., Peschel, A. & Kretschmer, D. Short-chain fatty acid and FFAR2 activation \u2013 a new option for treating infections?. Front. Cell. Infect. Microbiol. 11, 785833. https:\/\/doi.org\/10.3389\/fcimb.2021.785833 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"47309_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01707-19","volume":"94","author":"G Wang","year":"2020","unstructured":"Wang, G. et al. The G protein-coupled receptor FFAR2 promotes internalization during influenza A virus entry. J. Virol. 94(2), e01707-19. https:\/\/doi.org\/10.1128\/JVI.01707-19 (2020).","journal-title":"J. Virol."},{"issue":"1","key":"47309_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","volume":"160","author":"AD Sperber","year":"2021","unstructured":"Sperber, A. D. et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology 160(1), 99-114.e3. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.014 (2021).","journal-title":"Gastroenterology"},{"issue":"18","key":"47309_CR11","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.3748\/wjg.v12.i18.2846","volume":"12","author":"J Zhao","year":"2006","unstructured":"Zhao, J., Fr\u00f8kjaer, J. B., Drewes, A. M. & Ejskjaer, N. Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus. World J. Gastroenterol. 12(18), 2846\u201357. https:\/\/doi.org\/10.3748\/wjg.v12.i18.2846 (2006).","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"47309_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4239\/wjd.v4.i3.51","volume":"4","author":"B Krishnan","year":"2013","unstructured":"Krishnan, B., Babu, S., Walker, J., Walker, A. B. & Pappachan, J. M. Gastrointestinal complications of diabetes mellitus. World J. Diabetes 4(3), 51\u201363. https:\/\/doi.org\/10.4239\/wjd.v4.i3.51 (2013).","journal-title":"World J. Diabetes"},{"issue":"4","key":"47309_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5114\/pg.2020.101556","volume":"15","author":"R Kadaj-Lipka","year":"2020","unstructured":"Kadaj-Lipka, R. & Rydzewska, G. Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients. Gastroenterology Review 15(4), 289\u201393. https:\/\/doi.org\/10.5114\/pg.2020.101556 (2020).","journal-title":"Gastroenterology Review"},{"issue":"4","key":"47309_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.dld.2017.01.142","volume":"49","author":"HN Liu","year":"2017","unstructured":"Liu, H. N. et al. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Dig. Liver Dis. 49(4), 331\u20137. https:\/\/doi.org\/10.1016\/j.dld.2017.01.142 (2017).","journal-title":"Dig. Liver Dis."},{"issue":"16","key":"47309_CR15","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s00018-017-2509-x","volume":"74","author":"GA Weiss","year":"2017","unstructured":"Weiss, G. A. & Hennet, T. Mechanisms and consequences of intestinal dysbiosis. Cell. Mol. Life Sci. 74(16), 2959\u201377. https:\/\/doi.org\/10.1007\/s00018-017-2509-x (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"47309_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep12693","volume":"5","author":"M Pozuelo","year":"2015","unstructured":"Pozuelo, M. et al. Reduction of butyrate- and methane-producing microorganisms in patients with irritable bowel syndrome. Sci. Rep. 5, 12693. https:\/\/doi.org\/10.1038\/srep12693 (2015).","journal-title":"Sci. Rep."},{"key":"47309_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.805481","volume":"12","author":"K Li","year":"2022","unstructured":"Li, K. et al. Effects of short-chain fatty acid modulation on potentially diarrhea-causing pathogens in yaks through metagenomic sequencing. Front. Cell. Infect. Microbiol. 12, 805481. https:\/\/doi.org\/10.3389\/fcimb.2022.805481 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"47309_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108273","volume":"239","author":"T Ikeda","year":"2022","unstructured":"Ikeda, T., Nishida, A., Yamano, M. & Kimura, I. Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases. Pharmacol. Ther. 239, 108273. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108273 (2022).","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"47309_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41574-020-00459-w","volume":"17","author":"J Ghislain","year":"2021","unstructured":"Ghislain, J. & Poitout, V. Targeting lipid GPCRs to treat type 2 diabetes mellitus - Progress and challenges. Nat. Rev. Endocrinol. 17(3), 162\u201375. https:\/\/doi.org\/10.1038\/s41574-020-00459-w (2021).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"47309_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1017\/S095442241700018X","volume":"31","author":"YA Kim","year":"2018","unstructured":"Kim, Y. A., Keogh, J. B. & Clifton, P. M. Probiotics, prebiotics, synbiotics and insulin sensitivity. Nutr. Res. Rev. 31(1), 35\u201351. https:\/\/doi.org\/10.1017\/S095442241700018X (2018).","journal-title":"Nutr. Res. Rev."},{"issue":"1","key":"47309_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1152\/physrev.00041.2018","volume":"100","author":"I Kimura","year":"2020","unstructured":"Kimura, I., Ichimura, A., Ohue-Kitano, R. & Igarashi, M. Free fatty acid receptors in health and disease. Physiol. Rev. 100(1), 171\u2013210. https:\/\/doi.org\/10.1152\/physrev.00041.2018 (2020).","journal-title":"Physiol. Rev."},{"key":"47309_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1118529","volume":"14","author":"K Kasarello","year":"2023","unstructured":"Kasarello, K., Cudnoch-Jedrzejewska, A. & Czarzasta, K. Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front. Microbiol. 14, 1118529. https:\/\/doi.org\/10.3389\/fmicb.2023.1118529 (2023).","journal-title":"Front. Microbiol."},{"issue":"3","key":"47309_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41574-020-00459-w","volume":"17","author":"J Ghislain","year":"2021","unstructured":"Ghislain, J. & Poitout, V. Targeting lipid GPCRs to treat type 2 diabetes mellitus - Progress and challenges. Nat. Rev. Endocrinol. 17(3), 162\u201375. https:\/\/doi.org\/10.1038\/s41574-020-00459-w (2021).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6397","key":"47309_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1126\/science.aar4983","volume":"361","author":"SX Luo","year":"2018","unstructured":"Luo, S. X. et al. Regulation of feeding by somatostatin neurons in the tuberal nucleus. Science 361(6397), 76\u201381. https:\/\/doi.org\/10.1126\/science.aar4983 (2018).","journal-title":"Science"},{"issue":"1","key":"47309_CR25","doi-asserted-by":"publisher","first-page":"G53","DOI":"10.1152\/ajpgi.00346.2017","volume":"315","author":"CB Christiansen","year":"2018","unstructured":"Christiansen, C. B. et al. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. Am. J. Physiol. Gastrointest. Liver Physiol. 315(1), G53\u2013G65. https:\/\/doi.org\/10.1152\/ajpgi.00346.2017 (2018).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"47309_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.14744\/ejmo.2021.56223","volume":"5","author":"N Duggal","year":"2021","unstructured":"Duggal, N. & Kapoor, S. Role of gut microbiota in pathogenesis and treatment of type 2 diabetes. EJMO 5(2), 103\u201310. https:\/\/doi.org\/10.14744\/ejmo.2021.56223 (2021).","journal-title":"EJMO"},{"key":"47309_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104268","volume":"81","author":"H Ebrahimzadeh Leylabadlo","year":"2020","unstructured":"Ebrahimzadeh Leylabadlo, H., Sanaie, S., Sadeghpour Heravi, F., Ahmadian, Z. & Ghotaslou, R. From role of gut microbiota to microbial-based therapies in type 2 diabetes. Infect. Genet. Evol. 81, 104268. https:\/\/doi.org\/10.1016\/j.meegid.2020.104268 (2020).","journal-title":"Infect. Genet. Evol."},{"issue":"11","key":"47309_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113239","volume":"12","author":"O Ojo","year":"2020","unstructured":"Ojo, O., Feng, Q. Q., Ojo, O. O. & Wang, X. H. The role of dietary fibre in modulating gut microbiota dysbiosis in patients with type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials. Nutrients 12(11), 3239. https:\/\/doi.org\/10.3390\/nu12113239 (2020).","journal-title":"Nutrients"},{"issue":"7","key":"47309_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3748\/wjg.v13.i7.1079","volume":"13","author":"A Roda","year":"2007","unstructured":"Roda, A. et al. A new oral formulation for the release of sodium butyrate in the ileo-caecal region and colon. World J. Gastroenterol. 13(7), 1079\u20131084 (2007).","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"47309_CR30","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"BE Lacy","year":"2016","unstructured":"Lacy, B. E. et al. Bowel disorders. Gastroenterology 150(6), 1393-1407.e5 (2016).","journal-title":"Gastroenterology"},{"issue":"4","key":"47309_CR31","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1159\/000490981","volume":"47","author":"W Feng","year":"2018","unstructured":"Feng, W. et al. Sodium butyrate attenuates diarrhea in weaned piglets and promotes tight junction protein expression in colon in a GPR109A-dependent manner. Cell. Physiol. Biochem. 47(4), 1617\u201329. https:\/\/doi.org\/10.1159\/000490981 (2018).","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"47309_CR32","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1080\/21655979.2021.1920324","volume":"12","author":"Y He","year":"2021","unstructured":"He, Y. et al. Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism. Bioengineered 12(1), 1436\u201344. https:\/\/doi.org\/10.1080\/21655979.2021.1920324 (2021).","journal-title":"Bioengineered"},{"issue":"4","key":"47309_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13227","volume":"30","author":"X Long","year":"2018","unstructured":"Long, X. et al. Butyrate promotes visceral hypersensitivity in an IBS-like model via enteric glial cell-derived nerve growth factor. Neurogastroenterol. Motil. 30(4), e13227. https:\/\/doi.org\/10.1111\/nmo.13227 (2018).","journal-title":"Neurogastroenterol. Motil."},{"issue":"11","key":"47309_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/nu16111727","volume":"16","author":"X Ju","year":"2024","unstructured":"Ju, X., Jiang, Z., Ma, J. & Yang, D. Changes in fecal short-chain fatty acids in irritable bowel syndrome patients and effects of different interventions: A systematic review and meta-analysis. Nutrients 16(11), 1727 (2024).","journal-title":"Nutrients"},{"key":"47309_CR35","unstructured":"35. Kannampalli P, Pochiraju S, Chichlowski M, et al. Differential effects of short-chain fatty acids on visceral sensitivity in humans and rodents. Neurogastroenterology & Motility. 2011;23(7):e260\u2013e269."},{"key":"47309_CR36","unstructured":"36. Tarnowski W, Borycka-Kiciak K, Kiciak A, et al. Outcome of treatment with butyric acid in irritable bowel syndrome\u2013preliminary report. Gastroenterol Prakt. 2013;1:43\u2009\u2212\u20098."},{"issue":"2","key":"47309_CR37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1463-1318.2012.03152.x","volume":"15","author":"T Banasiewicz","year":"2013","unstructured":"Banasiewicz, T. et al. Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome. Colorectal Dis. 15(2), 204\u20139. https:\/\/doi.org\/10.1111\/j.1463-1318.2012.03152.x (2013).","journal-title":"Colorectal Dis."},{"issue":"6","key":"47309_CR38","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/S0016-5085(19)30508-6","volume":"78","author":"H Ruppin","year":"1980","unstructured":"Ruppin, H. et al. Absorption of short-chain fatty acids by the human large intestine. Gastroenterology 78(6), 1500\u20131507 (1980).","journal-title":"Gastroenterology"},{"key":"47309_CR39","unstructured":"39. Vidyasagar S, Tiwari SC, Sayed S, et al. Effects of butyrate on active sodium and chloride transport in mammalian colon. Am J Physiol Gastrointest Liver Physiol. 2002;283(5):G927\u2013G935."},{"issue":"3","key":"47309_CR40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/gut.2009.205476","volume":"60","author":"D Yu","year":"2011","unstructured":"Yu, D., Cheeseman, F. & Vanner, S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 60(3), 334\u2013340 (2011).","journal-title":"Gut"},{"issue":"7","key":"47309_CR41","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/MEG.0000000000000122","volume":"26","author":"UC Ghoshal","year":"2014","unstructured":"Ghoshal, U. C., Srivastava, D., Ghoshal, U. & Misra, A. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Eur. J. Gastroenterol. Hepatol. 26(7), 753\u2013760 (2014).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"47309_CR42","doi-asserted-by":"crossref","unstructured":"42. Kashyap S, et al. Critical appraisal of the small intestinal bacterial overgrowth hypothesis and breath testing: a clinical practice update. Neurogastroenterol Motil. 2024;36:e14569.","DOI":"10.1111\/nmo.14817"},{"key":"47309_CR43","unstructured":"43. Marathe CS, Rayner CK, Wu T, Jones KL, Horowitz M. Gastrointestinal disorders in diabetes. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000\u2013. Updated 2024 Feb 22. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553219\/"},{"issue":"2","key":"47309_CR44","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1053\/j.gastro.2015.05.007","volume":"149","author":"AE Bharucha","year":"2015","unstructured":"Bharucha, A. E., Zinsmeister, A. R., Schleck, C. D. & Melton, L. J. III. Delayed gastric emptying is associated with early and long-term hyperglycemia in type 1 diabetes mellitus. Gastroenterology 149(2), 330\u2013339. https:\/\/doi.org\/10.1053\/j.gastro.2015.05.007 (2015).","journal-title":"Gastroenterology"},{"issue":"4","key":"47309_CR45","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.rgmxen.2024.10.008","volume":"89","author":"JR Barrientos-\u00c1valos","year":"2024","unstructured":"Barrientos-\u00c1valos, J. R. et al. Gastrointestinal adverse effects of old and new antidiabetics: How do we deal with them in real life?. Rev. Gastroenterol. Mex. (Engl. Ed.) 89(4), 521\u2013532. https:\/\/doi.org\/10.1016\/j.rgmxen.2024.10.008 (2024).","journal-title":"Rev. Gastroenterol. Mex. (Engl. Ed.)"},{"key":"47309_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cbi.2016.06.007","volume":"254","author":"S Khan","year":"2016","unstructured":"Khan, S. & Jena, G. Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: A comparative study with metformin. Chem. Biol. Interact. 254, 124\u201334. https:\/\/doi.org\/10.1016\/j.cbi.2016.06.007 (2016).","journal-title":"Chem. Biol. Interact."},{"key":"47309_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.etap.2018.09.002","volume":"64","author":"Y Hu","year":"2018","unstructured":"Hu, Y. et al. Sodium butyrate mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of endoplasmic reticulum stress. Environ. Toxicol. Pharmacol. 64, 112\u201321. https:\/\/doi.org\/10.1016\/j.etap.2018.09.002 (2018).","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"3","key":"47309_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1530\/JOE-18-0137","volume":"238","author":"YH Xu","year":"2018","unstructured":"Xu, Y. H. et al. Sodium butyrate supplementation ameliorates diabetic inflammation in db\/db mice. J. Endocrinol. 238(3), 231\u201344. https:\/\/doi.org\/10.1530\/JOE-18-0137 (2018).","journal-title":"J. Endocrinol."},{"issue":"27","key":"47309_CR49","doi-asserted-by":"publisher","first-page":"7694","DOI":"10.1021\/acs.jafc.9b02083","volume":"67","author":"WQ Zhang","year":"2019","unstructured":"Zhang, W. Q. et al. Sodium butyrate improves liver glycogen metabolism in type 2 diabetes mellitus. J. Agric. Food Chem. 67(27), 7694\u2013705. https:\/\/doi.org\/10.1021\/acs.jafc.9b02083 (2019).","journal-title":"J. Agric. Food Chem."},{"issue":"11","key":"47309_CR50","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1055\/s-0043-119089","volume":"49","author":"N Roshanravan","year":"2017","unstructured":"Roshanravan, N. et al. Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: A randomized double-blind, placebo-controlled trial. Horm. Metab. Res. 49(11), 886\u201391. https:\/\/doi.org\/10.1055\/s-0043-119089 (2017).","journal-title":"Horm. Metab. Res."},{"issue":"7","key":"47309_CR51","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","volume":"58","author":"Z Gao","year":"2009","unstructured":"Gao, Z. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58(7), 1509\u201317. https:\/\/doi.org\/10.2337\/db08-1637 (2009).","journal-title":"Diabetes"},{"issue":"12","key":"47309_CR52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.44912","volume":"5","author":"S Coppola","year":"2022","unstructured":"Coppola, S. et al. Therapeutic effects of butyrate on pediatric obesity: A randomized clinical trial. JAMA Netw. Open 5(12), e2244912. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.44912 (2022).","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"47309_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41424-018-0025-4","volume":"9","author":"K Bouter","year":"2018","unstructured":"Bouter, K. et al. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects. Clin. Transl. Gastroenterol. 9(5), 155. https:\/\/doi.org\/10.1038\/s41424-018-0025-4 (2018).","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"2","key":"47309_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis, C. Y., Morris, J. & Whorwell, P. J. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment. Pharmacol. Ther. 11(2), 395\u2013402 (1997).","journal-title":"Aliment. Pharmacol. Ther."}],"updated-by":[{"DOI":"10.1038\/s41598-026-60200-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47309-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47309-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47309-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:16:12Z","timestamp":1782915372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47309-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47309"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47309-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-60200-x","URL":"https:\/\/doi.org\/10.1038\/s41598-026-60200-x","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the ethical standards of the Declaration of Helsinki and approved by the Bioethics Committee of the National Medical Institute, Ministry of Internal Affairs and Administration (PIM MSWiA) in Warsaw, Poland. Written informed consent was obtained from all participants before their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"17404"}}